Nevertheless, TP53 mutations were more likely to be found in high‐grade lesions: they were identified in 9/54 (17%) of high‐grade neoplasms and 7/162 (4%) of low‐grade neoplasms (p = 0.007) (Figure 1A), in keeping with other studies [20, 25, 31]. The gene discussed is TP53; the disease is neoplasm.